Clinical Trials on Pleural Empyema in Japan
Total 23 results
-
Hyogo Medical UniversityMerck Sharp & Dohme LLCNot yet recruitingMalignant Pleural MesotheliomaJapan
-
Eli Lilly and CompanyCompletedMalignant Pleural MesotheriomaJapan
-
Kissei Pharmaceutical Co., Ltd.CompletedMalignant Pleural MesotheliomaJapan
-
Sumitomo Pharma Co., Ltd.CompletedNon-Small Cell Lung Cancer | Malignant Pleural MesotheliomaJapan
-
Bristol-Myers SquibbRecruiting
-
Yuka KadomatsuRecruitingRecurrence | Surgery | Spontaneous PneumothoraxJapan
-
Eli Lilly and CompanyCompletedMalignant Pleural MesotheliomaJapan
-
Grifols Therapeutics LLCGrifols Japan K.K.Completed
-
Grifols Therapeutics LLCGrifols Japan K.K.CompletedAlpha1-Antitrypsin DeficiencyJapan
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveJapan
-
Pulmonx CorporationRecruiting
-
Olympus CorporationTerminated
-
Merck Sharp & Dohme LLCCompleted
-
SanofiMerck Sharp & Dohme LLCActive, not recruitingNon-small Cell Lung Cancer | Pleural MesotheliomaChile, Korea, Republic of, Japan, Poland, Spain, United States, Argentina, Australia, France, Italy, Taiwan
-
Verastem, Inc.TerminatedMalignant Pleural MesotheliomaUnited States, Belgium, United Kingdom, Sweden, Italy, Netherlands, France, Japan, Australia, Canada, New Zealand, Norway, Poland, South Africa, Spain
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic Obstructive | Pulmonary EmphysemaUnited States, Spain, Denmark, Belgium, Korea, Republic of, Canada, Germany, United Kingdom, Sweden, Finland, Japan, Poland
-
AstraZenecaRecruitingUnresectable Pleural MesotheliomaDenmark, Italy, Australia, Korea, Republic of, Belgium, Poland, United States, Canada, Japan, United Kingdom, Spain, China, France, Taiwan, Norway, Brazil, Germany, Switzerland, South Africa, Turkey, Netherlands
-
AstraZenecaCompletedPart A and B: Advanced Solid Malignancies | Part C: Malignant MesotheliomaJapan
-
CSL BehringRecruitingAcute-graft-versus-host DiseaseUnited States, Korea, Republic of, Spain, Australia, Germany, Italy, Turkey, Japan
-
Novartis PharmaceuticalsRecruitingMesotheliomaAustralia, Switzerland, Italy, Spain, Canada, Germany, Japan, United Kingdom, Netherlands, United States, France
-
Boehringer IngelheimTerminatedMesotheliomaUnited States, Spain, Canada, United Kingdom, Belgium, Czechia, Sweden, Australia, Germany, Italy, Japan, Russian Federation, Israel, Poland, France, Netherlands, Austria, Mexico, Portugal, Egypt, Argentina, Croatia, Chile, Denmark, Norway and more
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompletedMesotheliomaBrazil, United States, China, Italy, Australia, Belgium, Chile, Colombia, France, Germany, Greece, Japan, Mexico, Netherlands, Poland, Romania, Russian Federation, South Africa, Switzerland, Turkey, United Kingdom
-
Novartis PharmaceuticalsRecruitingCarcinoma, Renal Cell | Carcinoma, Non-Small-Cell Lung | Nasopharyngeal Carcinoma | Carcinoma, Ovarian Epithelial | Mesothelioma | Squamous Cell Carcinoma of Head and Neck | Triple Negative Breast Neoplasms | Anal Cancer | Cutaneous Melanoma | Esophagogastric Cancer | Carcinoma, Thymic | High Microsatellite...Italy, Spain, Singapore, Germany, Taiwan, Japan, Canada, Hong Kong, United States